Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain)

Transfusion

Volumn 55, Issue 5, 2015, Pages 972-979

  Sauleda, Sílvia ^a,b   Ong, Edgar ^c   Bes, Marta ^a,b   Janssen, Alanna ^c   Cory, Robin ^c   Babizki, Maria ^c   Shin, Tim ^c   Lindquist, Andre ^c   Hoang, Anh ^c   Vang, Lee ^c   Piron, Maria ^a,b   Casamitjana, Natàlia ^a   Koppelman, Marco ^d   Danzig, Lisa ^e   Linnen, Jeffrey M ^c  

^a BANC DE SANG I TEIXITS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Gen Probe Incorporated   (United States)

^d CENTRAL LABORATORY   (Netherlands)

^e Grifols (formerly Novartis Diagnostics) California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; NUCLEIC ACID; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; BLOOD DONOR; BLOOD SAFETY; CONFIDENCE INTERVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS E VIRUS; HUMAN; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; PROTEIN DETERMINATION; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; RISK ASSESSMENT; RNA TRANSCRIPTION; SCREENING; SEROLOGY; SEROPREVALENCE; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD; ADOLESCENT; EPIDEMIOLOGY; GENETICS; MOLECULAR GENETICS; PATHOGENICITY; POLYMERASE CHAIN REACTION; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD DONORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS E VIRUS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84929207404     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12929     Document Type: Review

References (35)

1. Hoofnagle JH, Nelson KE, Purcell RH,. Hepatitis E. N Engl J Med 2012;367:1237-1244.
2. Reyes GR, Purdy MA, Kim JP, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990;247:1335-1339.
3. Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet 2012;379:2477-2488.
4. Dalton HR, Bendall R, Ljaz S, et al. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008;8:698-709.
5. Riveiro-Barciela M, Rodríguez-Frías F, Buti M,. Hepatitis E virus: new faces of an old infection. Ann Hepatol 2013;12:861-870.
6. Salam GD, Kumar A, Kar P, et al. Serum tumor necrosis factor-alpha level in hepatitis E virus-related acute viral hepatitis and fulminant hepatic failure in pregnant women. Hepatol Res 2013;43:826-835.
7. Kamal N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008;358:811-817.
8. Gérolami R, Moal V, Colson P,. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008;358:859-860.
9. Halac U, Béland K, Lapierre P, et al. Chronic hepatitis E infection in children with liver transplantation. Gut 2012;61:597-603.
10. Pischke S, Stiefel P, Franz B, et al. Chronic hepatitis E in heart transplant recipients. Am J Transplant 2012;12:3128-3133.
11. Kamal N, Weclawiak H, Guilbeau-Frugier C, et al. Hepatitis E virus and the kidney in solid-organ transplant patients. Transplantation 2012;93:617-623.
12. Riezebos-Brilman A, Puchhammer-Stöckl E, van der Weide HY, et al. Chronic hepatitis E infection in lung transplant recipients. J Heart Lung Transplant 2013;32:341-346.
13. Dalton HR, Bendall RP, Kaene FE, et al. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009;361:1025-1027.
14. Juhl D, Baylis SA, Blümel J, et al. Seroprevalence and incidence of hepatitis E virus infection in German blood donors. Transfusion 2014;54:49-56.
15. Slot E, Hogema BM, Riezebos-Brilman A, et al. Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill 2013;18:pii: 20550.
16. Mansuy JM, Bendall R, Legrand-Abravanel F, et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011;17:2309-2312.
17. Boxall E, Herborn A, Kochethu G, et al. Transfusion-transmitted hepatitis E in a "nonhyperendemic" country. Transfus Med 2006;16:79-83.
18. Colson P, Coze C, Gallian P, et al. Transfusion-associated hepatitis E, France. Emerg Infect Dis 2007;13:648-649.
19. Matsubayashi K, Nagaoka Y, Sakata H, et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 2004;44:934-940.
20. Tamura A, Shimizu YK, Tanaka T, et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res 2007;37:113-120.
21. Buti M, Dominguez A, Plans P, et al. Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain. Clin Vaccine Immunol 2006;13:1328-1332.
22. Buti M, Plans P, Dominguez A, et al. Prevalence of hepatitis E virus infection in children in the northeast of Spain. Clin Vaccine Immunol 2008;15:732-734.
23. Meng XJ, Purcell RH, Halbur PG, et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci U S A 1997;94:9860-9865.
24. Baylis SA, Hanschmann KM, Blümel J, et al.; HEV Collaborative Study Group. Standardization of hepatitis E virus initial study to evaluate a panel of HEV stains and investigate laboratory performance. J Clin Microbiol 2011;49:1234-1239.
25. Cleland A, Smith L, Crossan C, et al. Hepatitis E virus in Scottish blood donors. Vox Sang 2013;105:283-289.
26. Pittaras T, Valsami S, Mavrouli M, et al. Seroprevalence of hepatitis E virus in blood donors in Greece. Vox Sang 2014;106:387.
27. Beale MA, Tettmar K, Szypulska R, et al. Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors? Vox Sang 2011;100:340-342.
28. Hogema BM, Molier M, Slot E, et al. Past and present of hepatitis E in the Netherlands. Transfusion 2014. doi: 10.1111/trf.12733.
29. Baylis SA, Gartner T, Nick S, et al. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang 2012;103:89-90.
30. Mitsui T, Tsukamoto Y, Yamazaki C, et al. Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion. J Med Virol 2004;74:563-572.
31. Hauser L, Roque-Afonso AM, Beyloune A, et al. Hepatitis E transmission by transfusion of Intercept blood system-treated plasma. Blood 2014;123:796-797.
32. Hewitt PE, Ijaz S, Brailsford SR, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014 July 28. doi: 10.1016/S0140-6736(14)61034-5.
33. Feray C, Pawlotsky JM, Roque-Afonso AM, et al. Should we screen blood products for hepatitis E virus RNA? Lancet 2014;383:218.
34. Pawlotsky JM,. Hepatitis E screening for blood donations: an urgent need? Lancet 2014 July 28. doi: 10.1016/S0140-6736(14)61187-9.
35. Bosch MA, Contreras E, Madoz P, et al. The epidemiology of blood components transfusion in Catalonia, Northeastern Spain. Transfusion 2011;51:105-116.